This was a phase II study at the European Institute of Oncology (IEO) in Milan, Italy on 100 patients with stage I–IIIa breast cancer who were candidates for elective surgery.
In 2011 laboratory study, Metformin also showed effectiveness against hormone-negative breast cancer.
• Read more about Metformin and TNBC in my book, Surviving Triple-Negative Breast Cancer.
• Please consider a donation to Positives About Negative to keep this site going. This work is entirely supported by readers. Just click on the Donate button in the right of the page. Thank you!
1 comment:
I believe there are a couple of clinical trials looking into this. My oncologist wanted me to get into one, but "unfortunately" I was ineligible because I became diabetic from the steroids while on chemo. So, I get the Metformin without the clinical trial - and hopefully the benefits of it! Thank you for posting such interesting stuff.
Post a Comment